keyword
https://read.qxmd.com/read/38657271/a-rationally-designed-synthetic-antiviral-peptide-binder-targeting-the-receptor-binding-domain-of-sars-cov-2
#1
JOURNAL ARTICLE
Lalita Mohan Behera, Pulkit Kr Gupta, Manaswini Ghosh, Sucharita Shadangi, Soumendra Rana
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel coronavirus, is the causative agent responsible for the spread of the COVID19 pandemic across the globe. The global impact of the COVID19 pandemic, the successful approval of vaccines for controlling the pandemic, and the further resurgence of COVID19 necessitate the exploration and validation of alternative therapeutic avenues targeting SARS-CoV-2. The initial entry and further invasion by SARS-CoV-2 require strong protein-protein interactions (PPIs) between the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein and the human angiotensin-converting enzyme 2 (ACE2) receptors expressed on the cell surfaces of various tissues...
April 24, 2024: Journal of Physical Chemistry. B
https://read.qxmd.com/read/38657244/sequential-cd7-car-t-cell-therapy-and-allogeneic-hsct-without-gvhd-prophylaxis
#2
JOURNAL ARTICLE
Yongxian Hu, Mingming Zhang, Tingting Yang, Zhuomao Mo, Guoqing Wei, Ruirui Jing, Houli Zhao, Rongrong Chen, Cheng Zu, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Xiaolin Yuan, Qu Cui, Hongshan Guo, Yunxian Yu, Youqin Feng, Chunxiang Jin, Jiangtao Ren, Alex H Chang, Dongrui Wang, He Huang
BACKGROUND: Patients with relapsed or refractory hematologic cancers have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapy as a bridge to allogeneic hematopoietic stem-cell transplantation (HSCT) has the potential for long-term tumor elimination. However, pre-HSCT myeloablation and graft-versus-host disease (GVHD) prophylaxis agents have toxic effects and could eradicate residual CAR T cells and compromise antitumor effects. Whether the integration of CAR T-cell therapy and allogeneic HSCT can preserve CAR T-cell function and improve tumor control is unclear...
April 25, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38657235/antipathogenic-activities-of-volatile-organic-compounds-produced-by-bacillus-velezensis-lt1-against-sclerotium-rolfsii-lc1-the-pathogen-of-southern-blight-in-coptis-chinensis
#3
JOURNAL ARTICLE
Tao Tang, Fanfan Wang, Houyun Huang, Nengneng Xie, Jie Guo, Xiaoliang Guo, Yuanyuan Duan, Xiaoyue Wang, Qingfan Wang, Jingmao You
This study explores the antipathogenic properties of volatile organic compounds (VOCs) produced by Bacillus velezensis LT1, isolated from the rhizosphere soil of Coptis chinensis . The impact of these VOCs on the mycelial growth of Sclerotium rolfsii LC1, the causative agent of southern blight in C. chinensis , was evaluated using a double Petri-dish assay. The biocontrol efficacy of these VOCs was further assessed through leaf inoculation and pot experiments. Antifungal VOCs were collected using headspace solid-phase microextraction (SPME), and their components were identified via gas chromatography-mass spectrometry (GC-MS)...
April 24, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38656972/tesofensine-a-novel-antiobesity-drug-silences-gabaergic-hypothalamic-neurons
#4
JOURNAL ARTICLE
Claudia I Perez, Jorge Luis-Islas, Axel Lopez, Xarenny Diaz, Omar Molina, Benjamin Arroyo, Mario G Moreno, Elvi Gil Lievana, Esmeralda Fonseca, Gilberto Castañeda-Hernández, Ranier Gutierrez
Obesity is a major global health epidemic that has adverse effects on both the people affected as well as the cost to society. Several anti-obesity drugs that target GLP-1 receptors have recently come to the market. Here, we describe the effects of tesofensine, a novel anti-obesity drug that acts as a triple monoamine neurotransmitter reuptake inhibitor. Using various techniques, we investigated its effects on weight loss and underlying neuronal mechanisms in mice and rats. These include behavioral tasks, DeepLabCut videotaped analysis, electrophysiological ensemble recordings, optogenetic activation, and chemogenetic silencing of GABAergic neurons in the Lateral Hypothalamus (LH)...
2024: PloS One
https://read.qxmd.com/read/38656557/first-in-human-study-of-alpibectir-bvl-gsk098-a-novel-potent-anti-tb-drug
#5
JOURNAL ARTICLE
Michel Pieren, Ana Abáigar Gutiérrez-Solana, Rosa María Antonijoan Arbós, Gary W Boyle, Myriam Davila, Maria Davy, Marc Gitzinger, Lisa Husband, María S Martínez-Martínez, Dolores Ochoa Mazarro, Eleni Pefani, Sophie L Penman, Modesto J Remuiñán, Georgios Vlasakakis, Markus Zeitlinger, Glenn E Dale
BACKGROUND: The clinical candidate alpibectir augments the activity of, and overcomes resistance to, the anti-TB drug ethionamide in vitro and in vivo. OBJECTIVES: A Phase 1, double-blind, randomized, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics (PK) and food effect of alpibectir administered as single and multiple oral doses in healthy volunteers (NCT04654143). METHODS: Eighty participants were randomized...
April 24, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38656240/interleukin-antagonists-for-atopic-dermatitis-a-new-era-of-therapy
#6
REVIEW
Aikaterini Tsiogka, Eleni Paschou, Dimitra Koumaki, Efstratios Vakirlis, Stamatios Gregoriou
INTRODUCTION: Over the last decade, increasing understanding of the immunopathogenesis of atopic dermatitis (AD) enabled the recognition of multiple therapeutic targets and subsequently the development of novel, highly effective systemic treatments, including interleukin (IL)-antagonists. To date, the IL-4Ra-inhibitor dupilumab, and the IL-13 inhibitor tralokinumab, have gained regulatory approval in Europe for the treatment of moderate-to-severe AD, while more than 70 new therapeutics are currently in development...
April 24, 2024: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/38656226/structural-and-functional-characterization-of-fabg4-from-mycolicibacterium-smegmatis
#7
JOURNAL ARTICLE
Xinping Ran, Prashit Parikh, Jan Abendroth, Tracy L Arakaki, Matthew C Clifton, Thomas E Edwards, Donald D Lorimer, Stephen Mayclin, Bart L Staker, Peter Myler, Krystle J McLaughlin
The rise in antimicrobial resistance is a global health crisis and necessitates the development of novel strategies to treat infections. For example, in 2022 tuberculosis (TB) was the second leading infectious killer after COVID-19, with multi-drug-resistant strains of TB having an ∼40% fatality rate. Targeting essential biosynthetic pathways in pathogens has proven to be successful for the development of novel antimicrobial treatments. Fatty-acid synthesis (FAS) in bacteria proceeds via the type II pathway, which is substantially different from the type I pathway utilized in animals...
April 1, 2024: Acta Crystallographica. Section F, Structural Biology Communications
https://read.qxmd.com/read/38656138/-in-vitro-activity-of-gepotidacin-and-comparator-antimicrobials-against-isolates-of-nontuberculous-mycobacteria-ntm
#8
JOURNAL ARTICLE
Barbara A Brown-Elliott, Georgie Bush, M Dolores Hughes, Eliana Rodriguez, Chase A Weikel, Sharon B Min, Richard J Wallace
Novel antimicrobials are needed to treat rising nontuberculous mycobacteria (NTM) infections. Using standard broth microdilution methods, 68 NTM isolates were tested against gepotidacin, a new, first-in-class, oral triazaacenaphthylene bacterial topoisomerase inhibitor. MICs varied (0.25 to >64 µg/mL) with the lowest being M. fortuitum complex (0.25-8 µg/mL), M. mucogenicum complex (1-2 µg/mL), M. kansasii (0.25-8 µg/mL), and M. marinum (4-16 µg/mL). Testing greater numbers of some species is suggested to better understand gepotidacin activity against NTM...
April 24, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38655868/a-potential-multitarget-insect-growth-regulator-candidate-design-synthesis-and-biological-activity-of-novel-acetamido-derivatives-containing-hexacyclic-pyrazole-carboxamides
#9
JOURNAL ARTICLE
Bingbo Guo, Lei Chen, Shihui Luo, Chunying Wang, Yanjiao Feng, Xiaoyang Li, Congwang Cao, Li Zhang, Qing Yang, Xiaoming Zhang, Xinling Yang
Insect growth regulators (IGRs) are important green insecticides that disrupt normal growth and development in insects to reduce the harm caused by pests to crops. The ecdysone receptor (EcR) and three chitinases Of ChtI, Of ChtII, and Of Chi-h are closely associated with the molting stage of insects. Thus, they are considered promising targets for the development of novel insecticides such as IGRs. Our previous work identified a dual-target compound 6j , which could act simultaneously on both EcR and Of ChtI...
April 24, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38655602/discovery-of-novel-fgfr4-inhibitors-through-a-build-up-fragment-strategy
#10
JOURNAL ARTICLE
Jihyung Kim, Chang Gyun Im, Kyujin Oh, Ji Min Lee, Fatimah Al-Rubaye, Kyung Hoon Min
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. FGFR4 has been implicated in HCC progression, making it a promising therapeutic target. We introduce an approach for identifying novel FGFR4 inhibitors by sequentially adding fragments to a common warhead unit. This strategy resulted in the discovery of a potent inhibitor, 4c , with an IC50 of 33 nM and high selectivity among members of the FGFR family. Although further optimisation is required, our approach demonstrated the potential for discovering potent FGFR4 inhibitors for HCC treatment, and provides a useful method for obtaining hit compounds from small fragments...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38655589/bacteriophages-as-a-potential-substitute-for-antibiotics-a-comprehensive-review
#11
REVIEW
Shruti O Kushwaha, Santosh Kumar Sahu, Virendra Kumar Yadav, Mayuri C Rathod, Dhaval Patel, Dipak Kumar Sahoo, Ashish Patel
Over the years, the administration of antibiotics for the purpose of addressing bacterial infections has become increasingly challenging due to the increased prevalence of antimicrobial resistance exhibited by various strains of bacteria. Multidrug-resistant (MDR) bacterial species are rising due to the unavailability of novel antibiotics, leading to higher mortality rates. With these conditions, there is a need for alternatives in which phage therapy has made promising results. Phage-derived endolysins, phage cocktails, and bioengineered phages are effective and have antimicrobial properties against MDR and extensively drug-resistant strains...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38655368/design-synthesis-biological-and-computational-screening-of-novel-pyridine-based-thiadiazole-derivatives-as-prospective-anti-inflammatory-agents
#12
JOURNAL ARTICLE
Naresh Podila, Naveen Kumar Penddinti, Mithun Rudrapal, Gourav Rakshit, Sathish Kumar Konidala, Veera Shakar Pulusu, Richie R Bhandare, Afzal B Shaik
In this study, a novel series of pyridine-based thiadiazole derivatives ( NTD1-NTD5 ) were synthesized as prospective anti-inflammatory agents by combining substituted carboxylic acid derivatives of 5-substituted-2-amino-1,3,4-thiadiazole with nicotinoyl isothiocyanate in the presence of acetone. The newly synthesized compounds were characterized by FTIR, 1 H NMR, 13 C NMR, and mass spectrometry. First, the compounds underwent rigorous in vivo testing for acute toxicity and anti-inflammatory activity and the results revealed that three compounds- NTD1 , NTD2 , and NTD3 , displayed no acute toxicity and significant anti-inflammatory activity, surpassing the efficacy of the standard drug, diclofenac...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655206/discovery-of-anti-cd47-peptides-as-innate-immune-checkpoint-inhibitors
#13
JOURNAL ARTICLE
Bahaa Mustafa, John Fetse, Sashi Kandel, Chien-Yu Lin, Pratik Adhikary, Umar-Farouk Mamani, Yanli Liu, Mohammed Nurudeen Ibrahim, Mohammed Alahmari, Kun Cheng
Cancer immunotherapy targeting adaptive immune cells has been attracting considerable interest due to its great success in treating multiple cancers. Recently, there is also increasing interest in agents that can stimulate innate immune cell activities. Immune checkpoint inhibitors targeting innate immune cells can block inhibitory interactions ('don't eat me' signals) between tumor cells and phagocytes. CD47 is a transmembrane protein overexpressed in various cancers and acts as a potent 'do not eat me' signal that contributes to the immune evasion of cancer cells...
December 2023: Advanced Therapeutics
https://read.qxmd.com/read/38655092/molecular-targeted-therapies-for-cutaneous-squamous-cell-carcinoma-recent-developments-and-clinical-implications
#14
REVIEW
Harpreet Singh, Hitesh Chopra, Inderbir Singh, Sourav Mohanto, Mohammed Gulzar Ahmed, Shruti Ghumra, Anmol Seelan, Manisha Survase, Arvind Kumar, Amrita Mishra, Arun Kumar Mishra, Mohammad Amjad Kamal
Cutaneous Squamous Cell Carcinoma (cSCC) is a common and potentially fatal type of skin cancer that poses a significant threat to public health and has a high prevalence rate. Exposure to ultraviolet radiation on the skin surface increases the risk of cSCC, especially in those with genetic syndromes like xerodermapigmentosum and epidermolysis bullosa. Therefore, understanding the molecular pathogenesis of cSCC is critical for developing personalized treatment approaches that are effective in cSCC. This article provides a comprehensive overview of current knowledge of cSCC pathogenesis, emphasizing dysregulated signaling pathways and the significance of molecular profiling...
2024: EXCLI Journal
https://read.qxmd.com/read/38655088/immunomodulatory-effects-of-hydatid-antigens-on-mesenchymal-stem-cells-gene-expression-alterations-and-functional-consequences
#15
JOURNAL ARTICLE
Xin Wang, Wubulikasimu Mijiti, Zhifei Yi, Qiyu Jia, Junchao Ma, Zengru Xie
BACKGROUND: Cystic echinococcosis, caused by the larval stage of Echinococcus granulosus , remains a global health challenge. Mesenchymal stem cells (MSCs) are renowned for their regenerative and immunomodulatory properties. Given the parasite's mode of establishment, we postulate that MSCs likely play a pivotal role in the interaction between the parasite and the host. This study aims to explore the response of MSCs to antigens derived from Echinococcus granulosus , the etiological agent of hydatid disease, with the hypothesis that exposure to these antigens may alter MSC function and impact the host's immune response to the parasite...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38655062/novel-survey-distribution-methods-impact-on-antimicrobial-resistance-research-outcomes
#16
JOURNAL ARTICLE
Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
No abstract text is available yet for this article.
April 2024: JAC-antimicrobial resistance
https://read.qxmd.com/read/38654867/tolerance-to-preoperative-placement-of-electrodes-for-neuromuscular-monitoring-using-the-tetragraph%C3%A2
#17
JOURNAL ARTICLE
Leah M Espinal, Sidhant Kalsotra, Julie Rice-Weimer, Sibelle A Yemele Kitio, Joseph D Tobias
BACKGROUND: Quantitative train-of-four (TOF) monitoring has recently been shown to be feasible in infants and children using a novel electromyography (EMG)-based monitor with a pediatric-sized self-adhesive sensor. However, placement of the sensor and initiation of TOF monitoring may require additional time in the operating room (OR), delaying workflow and the time to induction of anesthesia. The current study evaluates the feasibility of placing the self-adhesive sensor in the preoperative holding area in pediatric patients before arrival to the OR...
2024: Saudi Journal of Anaesthesia
https://read.qxmd.com/read/38654653/the-preclinical-discovery-and-clinical-evaluation-of-tirzepatide-for-the-treatment-of-type-2-diabetes
#18
REVIEW
Ioannis Avgerinos, Panagiota Kakotrichi, Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas
INTRODUCTION: Despite numerous antidiabetic medications available for the treatment of type 2 diabetes, a substantial percentage of patients fail to achieve optimal glycemic control. Furthermore, the escalating obesity pandemic underscores the urgent need for effective relevant pharmacotherapies. Tirzepatide, a novel dual GIP and GLP-1 receptor agonist, offers a promising therapeutic option. AREAS COVERED: This review describes the discovery and clinical development of tirzepatide...
May 2024: Expert Opinion on Drug Discovery
https://read.qxmd.com/read/38654633/a-detailed-density-functional-theory-exploration-of-the-photodissociation-mechanism-of-ruthenium-complexes-for-photoactivated-chemotherapy
#19
JOURNAL ARTICLE
Daniele Belletto, Fortuna Ponte, Gloria Mazzone, Emilia Sicilia
Polypyridyl Ru(II) complexes have attracted much attention due to their potential as light-activatable anticancer agents in photoactivated chemotherapy (PACT). The action of ruthenium-based PACT compounds relies on the breaking of a coordination bond between the metal center and an organic ligand via a photosubstitution reaction. Here, a detailed computational investigation of the photophysical properties of a novel trisheteroleptic ruthenium complex, [Ru(dpp)(bpy)(mtmp)]2+ (dpp = 4,7-diphenyl-1,10-phenanthroline, bpy = 2,2'-bipyridine and mtmp = 2-methylthiomethylpyridine), has been carried out by means of DFT and its time-dependent extension...
April 24, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38654553/the-trace-amine-associated-receptor-1-agonists-non-dopaminergic-antipsychotics-or-covert-modulators-of-d2-receptors
#20
JOURNAL ARTICLE
Gavin P Reynolds
A major effort of the pharmaceutical industry has been to identify and market drug treatments that are effective in ameliorating the symptoms of psychotic illness but without the limitations of the current treatments acting at dopamine D2 receptors. These limitations include the induction of a range of adverse effects, the inadequate treatment response of a substantial proportion of people with schizophrenia, and the generally poor response to negative and cognitive features of the disease. Recently introduced drug treatments have gone some way to avoiding the first of these, with a reduced propensity for weight gain, cardiovascular risk and extrapyramidal motor effects...
April 23, 2024: Journal of Psychopharmacology
keyword
keyword
33356
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.